Melanoom trials
- MIND-DC (gesloten voor inclusie)
- Study of the Safety and Efficacy of IMCgp100 Compared with Investigator’s Choice in HLA-A*0201 (gesloten voor inclusie)
- 2125-MEL-301 (Illuminate 301) (gesloten voor inclusie)
- A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)
- A phase 3, randomized, open-label study of NKTR-214
- ADMEC-O (gesloten voor inclusie)
- Adoptive Therapy With TCR Gene-engineered T Cells to Treat Patients With MAGE-C2-positive Melanoma and Head and Neck Cancer (MC2TCR)
- An open label Phase I PET imaging study to investigate the biodistribution and tumor uptake of [89Zr]Zr-BI 765063 in patients with head and neck squamous cell carcinoma, non-small cell lung cancer or melanoma who are also treated with ezabenlimab (open voor inclusie)
- BNI
- Chopin
- CLGK974X2101
- Cowboy studie
- DONIMI
- EORTC 1208 (Minitub)
- EORTC 1612
- GCT1021-02
- INTRIM
- M14TIL
- Masterkey 115
- NASAM
- NIVEC
- Opacin Neo extensiecohort (PRADO cohort) (gesloten)
- OpACIN-neo (gesloten voor inclusie)
- REPOSIT (gesloten voor inclusie)
- SAFE STOP Trial
- TIL and anti-PD1 in melanoma
- TRILOGY